EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Ischemia-free liver transplantation improves the prognosis of recipients using functionally marginal liver grafts

Shuai Wang, Xiaohong Lin, Yunhua Tang, Yichen Liang, Min Zhang, Zhonghao Xie, Yiwen Guo, Yuqi Dong, Qiang Zhao, Zhiyong Guo, Dongping Wang, Xiaoshun He und 2 weitere

Clinical and Molecular Hepatology · 2024

DOI: 10.3350/cmh.2024.0139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2024. Verfasst von Shuai Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Organ Transplant Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Liver Transplantation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: The shortage of donor liver hinders the development of liver transplantation. This study aimed to clarify the poor outcomes of functionally marginal liver grafts (FMLs) and provide evidence for the improvement of ischemia-free liver transplantation (IFLT) after FML transplantation.

Methods

Propensity score matching was used to control for confounding factors. The outcomes of the control group and FML group were compared to demonstrate the negative impact of FMLs on liver transplantation patients. We compared the clinical improvements of the different surgical types. To elucidate the underlying mechanism, we conducted bioinformatic analysis based on transcriptome and single-cell profiles.

Results

FMLs had a significantly greater hazard ratio (HR: 1.969, P=0.018) than did other marginal livers. A worse 90-day survival (Mortality: 12.3% vs. 5.0%, P=0.007) was observed in patients who underwent FML transplantation. Patients who received FMLs had a significant improvement in overall survival after IFLT (Mortality: 10.4% vs 31.3%, P=0.006). Pyroptosis and inflammation were inhibited in patients who underwent IFLT. The infiltration of natural killer cells was lower in liver grafts from these patients. Bulk transcriptome profiles revealed a positive relationship between IL-32 and Caspase 1 (R=0.73, P=0.01) and between IL-32 and Gasdermin D (R=0.84, P=0.0012).

Conclusions

FML is a more important negative prognostic parameter than other marginal liver parameters. IFLT might ameliorate liver injury in FMLs by inhibiting the infiltration of NK cells, consequently leading to the abortion of IL-32, which drives pyroptosis in monocytes and macrophages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationHumansMaleFemaleMiddle AgedPrognosisLiverAdultInterleukinsTranscriptomePyroptosisKiller Cells, NaturalGraft SurvivalTissue DonorsPropensity Score

Stichwörter der Autor:innen

Ischemia-free liver transplantationLiver transplantationMarginal liver graftsNormothermic machine perfusionStatic cold storageTransplantation immunology

Substanzen

Interleukins

Autor:innen und Institutionen

  • Organ Transplant Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangzhou, People's Republic of China.
  • Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation), Guangzhou, People's Republic of China.
  • Department of Thyroid and Breast Surgery, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.

Förderung

  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology
  • Guangdong Provincial International Cooperation Base of Science and Technology
  • China organ transplantation development foundation

Zitieren

APA

Wang, S., Lin, X., Tang, Y., Liang, Y., Zhang, M., Xie, Z., Guo, Y., Dong, Y., Zhao, Q., Guo, Z., Wang, D., He, X., Ju, W., & Chen, M. (2024). Ischemia-free liver transplantation improves the prognosis of recipients using functionally marginal liver grafts. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.0139

Vancouver

Wang S, Lin X, Tang Y, Liang Y, Zhang M, Xie Z, et al. Ischemia-free liver transplantation improves the prognosis of recipients using functionally marginal liver grafts. Clinical and Molecular Hepatology. 2024. doi:10.3350/cmh.2024.0139

BibTeX
@article{Wang2024,
  author = {Wang, Shuai and Lin, Xiaohong and Tang, Yunhua and Liang, Yichen and Zhang, Min and Xie, Zhonghao and Guo, Yiwen and Dong, Yuqi and Zhao, Qiang and Guo, Zhiyong and Wang, Dongping and He, Xiaoshun and Ju, Weiqiang and Chen, Maogen},
  title = {Ischemia-free liver transplantation improves the prognosis of recipients using functionally marginal liver grafts},
  journal = {Clinical and Molecular Hepatology},
  year = {2024},
  doi = {10.3350/cmh.2024.0139}
}
Kostenlos starten →